The Patent Finder

Methods and Pharmaceutical Compositions for the Treatment of FGFR3-RELATED Chondrodysplasias

Fondation Imagine

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 12,257,232Methods and Pharmaceutical Compositions for the Treatment of FGFR3-RELATED Chondrodysplasias
In force
 · High confidence
Inserm (Institut National de la Sante et de la Recherche Medicale), Universite de Paris, Fondation Imagine, Assistance Publique-Hopitaux de Paris (Aphp) and Universidad de GranadaIn force
High confidence
US 11,951,090Methods and Pharmaceutical Compositions for the Treatment of FGFR3-RELATED Chondrodysplasias
In force
 · High confidence
Université Paris CitéIn force
High confidence
2 of 2 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Fondation Imagine.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited